The Patent Finder

Nutri Co., Ltd.

10 patents currently held · Updated Nov 21, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
3
Ending by 2030
Jan 2029
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 2 fees due Feb 20 to 22, 2027 · next Feb 20
  • 2 fees due Aug 25 to 27, 2027 · next Aug 25

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 10 of 10

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 10,568,906Composition for improving nutritional status, reducing frequency of fever and/or increasing immunocompetence of the elderly
In force
 · USPTO record
In forceUSPTO record
US 9,511,141Composition for reducing oxidative stress and/or side effects occurring during cancer chemotherapy or improving nutritional status during cancer chemotherapy
In force
 · USPTO record
In forceUSPTO record
US 9,872,515Low-Concentration Nutritional Composition
In force
 · High confidence
In forceHigh confidence
US 10,383,893Composition for reducing the level of glucose, malondialdehyde-modified LDL, homocysteine and/or C-reactive protein in blood
In force
 · USPTO record
In forceUSPTO record
US 10,806,167Gelling composition
In force
 · USPTO record
In forceUSPTO record
US 10,960,034MRSA infection protective agent
In force
 · USPTO record
In forceUSPTO record
US 11,911,420Prophylactic and/or therapeutic agents for Streptococcus pneumoniae infection
In force
 · USPTO record
In forceUSPTO record
US 12,053,496Agent for prevention and/or treatment of Pseudomonas aeruginosa infection
In force
 · USPTO record
In forceUSPTO record
US 11,730,776Preventive and/or therapeutic agent for clostridium difficile infection
In force
 · USPTO record
In forceUSPTO record
US 12,616,766Clostridiodes Difficile Growth Inhibitor
In force
 · High confidence
In forceHigh confidence
Also on record, not counted in the 10: 1 lapsed for an unpaid fee · 4 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

1 abandoned · 2 no status recorded

Showing 1 to 3 of 3, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.

ApplicationTitleFiledStatus
18/685,863Aug 18, 2022No status recorded
17/258,355Jul 17, 2019No status recorded
16/477,356Highly Dispersible Dextrin and Production Method ThereforJan 11, 2018Abandoned
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited